-+ 0.00%
-+ 0.00%
-+ 0.00%

SENTYNL THERAPEUTICS- ON OPTION EXERCISE, SENTYNL TO COMMERCIALIZE ALVELESTAT IN U.S.; MEREO RETAINS REST OF WORLD RIGHTS

Reuters·08/11/2026 12:00:07

Please log in to view news